STRATA Skin Company Leadership
| SSKN Stock | USD 3.03 0.07 2.36% |
STRATA Skin's insiders are aggressively buying. The analysis of insiders' sentiment of trading STRATA Skin Sciences stock suggests that virtually all insiders are extremely bullish at this time. STRATA Skin employs about 99 people. The company is managed by 12 executives with a total tenure of roughly 16 years, averaging almost 1.0 years of service per executive, having 8.25 employees per reported executive.
| Dolev Rafaeli CEO CEO President |
| Michael Stewart CEO CEO and President and Director |
STRATA Skin's Insider Buying Vs Selling
100
Selling | Buying |
Latest Trades
| 2024-07-15 | Uri Geiger | Acquired 230573 @ 3.14 | View | ||
| 2023-12-01 | Shmuel Gov | Acquired 2000 @ 4.5 | View |
Monitoring STRATA Skin's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
STRATA |
STRATA Skin's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with STRATA Skin's future performance. Based on our forecasts, it is anticipated that STRATA will maintain a workforce of about 100 employees by December 2024.STRATA Skin Management Team Effectiveness
The company has return on total asset (ROA) of (0.0679) % which means that it has lost $0.0679 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6297) %, meaning that it created substantial loss on money invested by shareholders. STRATA Skin's management efficiency ratios could be used to measure how well STRATA Skin manages its routine affairs as well as how well it operates its assets and liabilities. As of the 28th of November 2024, Return On Tangible Assets is likely to drop to -0.4. In addition to that, Return On Capital Employed is likely to drop to -0.3. At this time, STRATA Skin's Asset Turnover is very stable compared to the past year.As of the 28th of November 2024, Common Stock Shares Outstanding is likely to grow to about 4 M, while Net Loss is likely to drop (3.3 M).
STRATA Skin Workforce Comparison
STRATA Skin Sciences is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 6,138. STRATA Skin claims roughly 99.0 in number of employees contributing just under 2% to equities under Health Care industry.
The company has Profit Margin (PM) of (0.25) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.06) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.06. STRATA Skin Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific STRATA Skin insiders, such as employees or executives, is commonly permitted as long as it does not rely on STRATA Skin's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, STRATA Skin insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2024-12-01 | 1.0 | 1 | 1 | 20,000 | 54,339 |
| 2023-12-01 | 3.3333 | 10 | 3 | 2,579,319 | 67,666 |
| 2022-06-01 | 4.0 | 4 | 1 | 102,560 | 55,490 |
| 2020-12-01 | 2.0 | 2 | 1 | 165,000 | 15,000 |
| 2018-06-01 | 4.8 | 24 | 5 | 2,054,910 | 1,557,628 |
| 2016-03-01 | 0.2 | 1 | 5 | 125,000 | 266,000 |
| 2015-09-01 | 3.0 | 3 | 1 | 1,037,500 | 0.00 |
| 2014-12-01 | 7.0 | 7 | 1 | 760,000 | 35,000 |
| 2014-03-01 | 3.3333 | 10 | 3 | 322,703 | 9,518,661 |
| 2013-03-01 | 2.0 | 2 | 1 | 22,886 | 2,886 |
| 2012-03-01 | 8.0 | 8 | 1 | 71,875 | 1,875 |
| 2010-12-01 | 4.5 | 9 | 2 | 104,500 | 83,738 |
| 2010-03-01 | 2.0 | 2 | 1 | 11,526 | 70,175 |
| 2009-12-01 | 4.0 | 12 | 3 | 72,838 | 7,628 |
| 2009-09-01 | 1.0 | 3 | 3 | 15,000 | 15,000 |
| 2009-03-01 | 23.0 | 23 | 1 | 47,000 | 5,000 |
| 2008-12-01 | 29.0 | 29 | 1 | 518,343 | 6,526 |
| 2008-09-01 | 0.5385 | 7 | 13 | 138,429 | 167,113 |
| 2008-06-01 | 0.4375 | 7 | 16 | 8,000 | 127,300 |
| 2008-03-01 | 0.3333 | 1 | 3 | 80,000 | 359,239 |
| 2007-12-01 | 15.0 | 30 | 2 | 270,900 | 3,000 |
| 2007-06-01 | 5.0 | 10 | 2 | 82,618 | 75,175 |
| 2007-03-01 | 1.6667 | 5 | 3 | 86,035 | 57,160 |
| 2006-12-01 | 0.5789 | 11 | 19 | 316,547 | 406,544 |
| 2006-09-01 | 1.0 | 2 | 2 | 4,245 | 61,900 |
| 2006-06-01 | 3.0 | 6 | 2 | 23,917 | 140,000 |
| 2006-03-01 | 4.0 | 4 | 1 | 122,721 | 94,717 |
| 2005-12-01 | 2.8333 | 17 | 6 | 171,907 | 24,807 |
STRATA Skin Notable Stakeholders
A STRATA Skin stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as STRATA Skin often face trade-offs trying to please all of them. STRATA Skin's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting STRATA Skin's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Dolev Rafaeli | CEO President | Profile | |
| Michael Stewart | CEO and President and Director | Profile | |
| John Gillings | VP Finance | Profile | |
| Shmuel Gov | Chief Officer | Profile | |
| Robert Moccia | CEO Pres | Profile | |
| William MBA | Ex Chairman | Profile | |
| Michael Goodman | Head Sales | Profile | |
| Darrell Rigel | Chief Advisor | Profile | |
| Keith Simeone | VP Sales | Profile | |
| Nikolai Kabelev | VP RD | Profile | |
| Christopher Lesovitz | Chief Officer | Profile | |
| Jay Sturm | General Secretary | Profile |
About STRATA Skin Management Performance
The success or failure of an entity such as STRATA Skin Sciences often depends on how effective the management is. STRATA Skin management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of STRATA management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the STRATA management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.38) | (0.40) | |
| Return On Capital Employed | (0.29) | (0.30) | |
| Return On Assets | (0.26) | (0.27) | |
| Return On Equity | (0.85) | (0.81) |
STRATA Skin Workforce Analysis
Traditionally, organizations such as STRATA Skin use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare STRATA Skin within its industry.STRATA Skin Manpower Efficiency
Return on STRATA Skin Manpower
| Revenue Per Employee | 336.9K | |
| Revenue Per Executive | 2.8M | |
| Net Loss Per Employee | 109.4K | |
| Net Loss Per Executive | 902.5K | |
| Working Capital Per Employee | 34K | |
| Working Capital Per Executive | 280.8K |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRATA Skin Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STRATA Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.60) | Revenue Per Share 9.347 | Quarterly Revenue Growth 0.022 | Return On Assets (0.07) | Return On Equity (0.63) |
The market value of STRATA Skin Sciences is measured differently than its book value, which is the value of STRATA that is recorded on the company's balance sheet. Investors also form their own opinion of STRATA Skin's value that differs from its market value or its book value, called intrinsic value, which is STRATA Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STRATA Skin's market value can be influenced by many factors that don't directly affect STRATA Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STRATA Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STRATA Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.